top of page
  • Facebook
  • Instagram
Peptide AWW.jpg

Peptide Therapy

Because healthy aging looks different for everyone.

As we age, our energy levels, recovery, and overall health needs change. Peptide research is exploring new approaches to tissue repair, inflammation, metabolism, and neurological health. At Alpha Women's Wellness, we consider your individual health history, goals, and the available medical evidence before discussing whether peptide therapy may be appropriate for you.

Cosmetic Dropper Close-Up

What Is Peptide Therapy?

Peptides are short chains of amino acids. Many occur naturally in the body and act as messengers, helping regulate hormone signaling, metabolism, and cellular function.​

​

Some peptide-based medications have established clinical uses, while others are still being investigated. The six peptides listed below are part of this emerging area of medicine, with human evidence and safety information that remain limited. At Alpha Women's Wellness, every treatment discussion begins with understanding your health, your goals, and what the medical evidence supports.

BPC-157

Tissue Repair & Recovery

BPC-157 is being studied for its potential role in tissue repair, digestive health, and inflammation. 

TB-500

Healing & Recovery

TB-500 is being investigated for its potential involvement in tissue repair and wound healing. 

KPV

Inflammation & Skin Health

KPV is being studied for its potential effects on inflammatory pathways, including those involving the skin and digestive system. 

MOTS-c

Metabolic Health

MOTS-c is being investigated for its role in cellular metabolism and energy regulation.

Semax

Neurological Health

Semax is being investigated for potential applications involving the nervous system. 

Epitalon

Sleep & Aging Research

Epitalon is being investigated for potential effects on sleep-related biological processes.

Important Information About Peptide Therapy

The six peptides listed above are included on the U.S. Department of Health and Human Services (HHS) 503A Interim Access List. HHS has issued a temporary enforcement discretion policy for qualifying compounding under specific conditions. 

​

These peptides are not FDA-approved, and compounded preparations have not been reviewed by the FDA for safety, effectiveness, or quality. Treatment availability is subject to applicable regulations and requires an individualized medical evaluation and prescription.

bottom of page